Abstract
The problems inherent in medicalized formulations and treatment of emotional distress and the paternalistic, authoritarian behavior of mental health professionals are consistently criticized by individuals with lived experience, and all of the participants, to be harmful and re-traumatizing. This includes the use of multiple, high-dose psychotropic drugs, hospitalizations, compulsory “treatment” orders in the community, medicalized language and framing of emotional experience, coercion, and so on. Service users describe experiences of force and coercion in mental health services as akin to imprisonment, being ambushed, and feeling terrorized. Conversely, individuals experiencing psychological or spiritual crises often describe this period as one fueled by a search for meaning and purpose. The system as a whole, however, is not built on a respect for the subjective and experience-based expertise of the service user; rather, it is predicated on an authoritarian form of social control and coercive practices. This chapter explores these practices and their impact.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allen, M., & Smith, V. F. (2001). Opening pandora’s box: The practical and legal dangers of involuntary outpatient commitment. Psychiatric Services, 52(3), 342–346.
Bjornestad, J., Bronnick, K., Davidson, L., Hegelstad, W. T. V., Joa, I., Kandal, O., … Johannessen, J. O. (2017). The central role of self-agency in clinical recovery from first episode psychosis. Psychosis, 9(2), 140–148. https://doi.org/10.1080/17522439.2016.1198828
Boevink, W. (2006). From being a disorder to dealing with life: An experiential exploration of the association between trauma and psychosis. Schizophrenia Bulletin, 32, 17–19.
Boevink, W. (2012). Towards recovery, empowerment and experiential expertise of users of psychiatric services. In P. Ryan, S. Ramon, & T. Greacen (Eds.), Empowerment, lifelong learning and recovery in mental health: Towards a new paradigm. New York, NY: Palgrave Macmillan.
Breggin, P. R. (2008). Medication madness: A psychiatrist exposes the dangers of mood-altering drugs. New York, NY: St. Martin’s Press.
British Psychological Society. (2013). Division of Clinical Psychology position statement on the classification of behaviour and experience in relation to functional psychiatric diagnoses: Time for a paradigm shift. Retrieved from http://dxrevisionwatch.files.wordpress.com/2013/05/position-statement-on-diagnosis-master-doc.pdf
Burstow, B. (2017). Psychiatric drugging of children and youth as a form of child abuse: Not a radical proposition. Ethical Human Psychology and Psychiatry, 19(1), 65–76.
Calton, T., Ferriter, M., Huband, N., & Spandler, H. (2008). A systematic review of the soteria paradigm for the treatment of people diagnosed with schizophrenia. Schizophrenia Bulletin, 34(1), 181–192. https://doi.org/10.1093/schbul/sbm047
Caplan, P. J. (1995). They say you’re crazy: How the world’s most powerful psychiatrists decide who’s normal. Reading, MA: Addison-Wesley.
Cartwright, C., Gibson, K., Read, J., Cowan, O., & Dehar, T. (2016). Long-term antidepressant use: Patient perspectives of benefits and adverse effects. Patient Preference and Adherence, 10, 1401–1407.
Chung, D., Ryan, C., Hadzi-Pavlovic, D., Singh, S., Stanton, C., & Large, M. (2017). Suicide rates after discharge from psychiatric facilities: A systematic review and meta-analysis. JAMA Psychiatry, 74(7), 694–702. https://doi.org/10.1001/jamapsychiatry.2017.1044
Cohen, O. (2005). How do we recover? An analysis of psychiatric survivor oral histories. Journal of Humanistic Psychology, 45(3), 333–354.
Corin, E., Thara, R., & Padmavati, R. (2004). Living through the staggering world: The play of signifiers in early psychosis in South India. In J. H. Jenkins & R. J. Barrett (Eds.), Schizophrenia, culture and subjectivity: The edge of experience. Cambridge: Cambridge University Press.
Deacon, B. J. (2013). The biomedical model of mental disorder: A critical analysis of its validity, utility, and effects on psychotherapy research. Clinical Psychology Review, 33, 846–861.
Dell, P. F. (1998). Axis II pathology in outpatients with dissociative identity disorder. Journal of Nervous and Mental Disorders, 186, 352–356.
Dillon, J. (2013, March). Just saying it as it is: Names matter; Language matters; Truth matters. Clinical Psychology Forum No. 243: British Psychological Society.
Ellason, J. W., Ross, C. A., & Fuchs, D. L. (1996). Lifetime axis I and II comorbidity and childhood trauma history in dissociative identity disorder. Psychiatry, 59, 255–266.
Fenton, W. S., Mosher, L., Herrell, J. M., & Blyler, C. R. (1998). Randomized trial of general hospital and residential alternative care for patients with severe and persistent mental illness. American Journal of Psychiatry, 155, 516–522.
Fleischhacker, W. W., Kane, J. M., Geier, J., Karayal, O., Kolluri, S., Eng, S. M., … Strom, B. L. (2014). Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial. Journal of Clinical Psychiatry, 75(3), e184–e190. https://doi.org/10.4088/JCP.13m08563
Gibson, S., Brand, S. L., Burt, S., Boden, Z. V., & Benson, O. (2013). Understanding treatment non-adherence in schizophrenia and bipolar disorder: A survey of what service users do and why. BMC Psychiatry, 13(1), 153.
Goldberg, D. (2011). The heterogeneity of “major depression”. World Psychiatry, 10(3), 226–228.
Gotzsche, P. C. (2015). Deadly psychiatry and organised denial. Denmark: People’s Press.
Greenfield, T. K., Stoneking, B. C., Humphreys, K., Sundby, E., & Bond, J. (2008). A randomized trial of a mental health consumer-managed alternative to civil commitment for acute psychiatric crisis. American Journal of Community Psychology, 42, 135–144.
Halpin, E., Kugathasan, V., Hulbert, C., Alvarez-Jimenez, M., & Bendall, S. (2016). Case formulation in young people with post-traumatic stress disorder and first-episode psychosis. Journal of Clinical Medicine, 5(11), 106. https://doi.org/10.3390/jcm5110106
Harrow, M., & Jobe, T. H. (2007). Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: A 15-year multifollow-up study. The Journal of Nervous and Mental Disease, 195(5), 406–414.
Harrow, M., Jobe, T. H., & Faull, R. N. (2012). Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychological Medicine, 42(10), 2145–2155.
Healy, D. (2012). Pharmageddon. Los Angeles, CA: University of California Press.
Healy, D., Herxheimer, A., & Menkes, D. B. (2006). Antidepressants and violence: Problems at the interface of medicine and law. Public Library of Science Medicine, 3(9), e372.
Hjorthoj, C. R., Madsen, T., Agerbo, E., & Nordentoft, M. (2014). Risk of suicide according to level of psychiatric treatment: A nationwide nested case-control study. Social Psychiatry and Psychiatric Epidemiology, 49, 1357–1365.
Hofer, F. X., Habermeyer, E., Mokros, A., Lau, S., & Gairing, S. K. (2015). The impact of legal coercion on the therapeutic relationship in adult schizophrenic patients. PLoS ONE, 10(4), e0124043. https://doi.org/10.1371/journal.pone.0124043
Huber, C. G., Schneeberger, A. R., Kowalinski, E., Frohlich, D., von Felten, S., Walter, M., … Lang, U. E. (2016). Suicide risk and absconding in psychiatric hospitals with and without open door policies: A 15-year observational study. Lancet Psychiatry, 3(9), 842–849.
Human Rights Council. (2009, December). Thematic study by the Office of the United Nations High Commissioner for Human Rights on the structure and role of national mechanisms for the implementation and monitoring of the Convention on the Rights of Persons with Disabilities (A-HRC-13-29). Annual report of the United Nations High Commissioner for Human Rights and reports of the Office of the High Commissioner and the Secretary-General. Retrieved from http://www.ohchr.org/EN/Issues/Disability/Pages/ThematicStudies.aspx
Karon, B. P. (2000). Effective psychoanalytic therapy of schizophrenia and other severe disorders. Washington, DC: American Psychological Association.
Kisely, S. R., Campbell, L., & Preston, N. J. (2011). Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD004408.pub3
Large, M., & Ryan, C. J. (2014). Disturbing findings about the risk of suicide and psychiatric hospitals. Journal of Social Psychiatry and Psychiatric Epidemiology, 40(9), 1353–1355.
Lloyd-Evans, B., Slade, M., Jagielska, D., & Johnson, S. (2009). Residential alternatives to acute psychiatric hospital admission: Systematic review. British Journal of Psychiatry, 195, 109–117.
Lucire, Y. (2016). Pharmacological iatrogenesis: Substance/medication-induced disorders that masquerade as mental illness. Epidemiology, 6(1). https://doi.org/10.4172/2161-1165.1000217
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013). Patient preference for psychological vs. pharmacologic treatment of psychiatric disorders: A meta-analytic review. Journal of Clinical Psychiatry, 74(6), 595–602.
McWade, B. (2016). Recovery-as-policy as a form of neoliberal state making. Intersectionalities: A Global Journal of Social Work Analysis, Research, Polity, and Practice, 5(3), 62–81.
Mead, S., & Copeland, M. E. (2000). What recovery means to us: Consumers’ perspectives. Community Mental Health Journal, 36(3), 315–328.
Mendez, J. E. (2013, March). Special Rapporteur on Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment. 22nd session of the Human Rights Council, Agenda Item 3, Geneva.
Metzl, J. M. (2010). The protest psychosis: How schizophrenia became a black disease. Boston, MA: Beacon Press.
Moilanen, J., Haapea, M., Jaaskelainen, E., Veijola, J., Isohanni, M., Koponen, H., & Miettunen, J. (2016). Long-term antipsychotic use and its association with outcomes in schizophrenia – the Northern Finland Birth Cohort 1966. European Psychiatry, 36, 7–14.
Moncrieff, J., Cohen, D., & Porter, S. (2013). The psychoactive effects of psychiatric medication: The elephant in the room. Journal of Psychoactive Drugs, 45(5), 409–415. https://doi.org/10.1080/02791072.2013.845328
Moore, T. J., & Furberg, C. D. (2017). The harms of antipsychotic drugs: Evidence from key studies. Drug Safety, 40(1), 3–14.
Mueser, K. T., Lu, W., Rosenberge, S. D., & Wolfe, R. (2010). The trauma of psychosis: Posttraumatic stress disorder and recent onset psychosis. Schizophrenia Research, 116, 217–227.
Murphy, R., McGuinness, D., Bainbridge, E., Brosnan, L., Felzmann, H., Keys, M., … Higgins, A. (2017). Service users’ experiences of involuntary hospital admission under the Mental Health Act 2001 in the Republic of Ireland. Psychiatric Services, 68(11), 1127–1135.
Murray, R. M., Quattrone, D., Natesan, S., Van Os, J., Nordentoft, M., Howes, O., … Taylor, D. (2016). Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? The British Journal of Psychiatry, 209(5), 361–365.
Newnes, C. (2016). Inscription, diagnosis, deception and the mental health industry. London: Palgrave Macmillan.
Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D. (2017). Discontinuing psychiatric medications: A survey of long-term users. Psychiatric Services, 68(12), 1232–1238.
Read, J. (2004). The invention of ‘schizophrenia’. In J. Read, L. Mosher, & R. P. Bentall (Eds.), Models of Madness. East Sussex: Brunner-Routledge.
Read, J., & Arnold, C. (2017). Is electroconvulsive therapy for depression more effective than placebo? A systematic review of studies since 2009. Ethical Human Psychology and Psychiatry, 19(1), 5–23.
Rowe, M. (2013). Alternatives to outpatient commitment. Journal of the American Academy of Psychiatry and the Law, 41(3), 332–336.
Schizophrenia Commission. (2012, November). The abandoned illness: A report by the Schizophrenia commission. Retrieved from https://www.rethink.org/media/514093/TSC_main_report_14_nov.pdf
Seikkula, J., Alakare, B., & Aaltonen, J. (2011). The comprehensive open-dialogue approach in Western Lapland: II. Long-term stability of acute psychosis outcomes in advanced community care. Psychosis, 3, 192–204.
Skodol, A. E., Gunderson, J. G., Pfohl, B., Widiger, T. A., Livesley, W. J., & Siever, L. J. (2002). The borderline diagnosis I: Psychopathology, comorbidity, and personality structure. Biological Psychiatry, 51(12), 936–950.
Sledge, W. H., Tebes, J., Rakfeldt, J., Davidson, L., Lyons, L., & Druss, B. G. (1996). Day hospital/crisis respite care versus inpatient care, Part 1: Clinical outcomes. American Journal of Psychiatry, 153, 1065–1073.
Steadman, H., Gounis, K., Dennis, D., Hopper, K., Roche, B., Swartz, M., & Robbins, P. (2001). Assessing the New York city involuntary outpatient commitment pilot program. Psychiatric Services, 52(3), 330–336.
Tandon, R. (2014). Schizophrenia and other psychotic disorders in Diagnostic and Statistical Manual of Mental Disorders (DSM)-5: Clinical implications of revisions from DSM-IV. Indian Journal of Psychological Medicine, 36(3), 223–225. https://doi.org/10.4103/0253-7176.135365
The Lancet Psychiatry. (2017). Psychiatry unlocked. The Lancet Psychiatry, 4(4), 261. https://doi.org/10.1016/s2215-0366(17)30081-0
Thomas, P., & Longden, E. (2013). Madness, childhood adversity and narrative psychiatry: Caring and the moral imagination. Medical Humanities, 39(2), 119–125.
van Os, J. (2016). “Schizophrenia” does not exist. BMJ, 352. https://doi.org/10.1136/bmj.i375
Wardenaar, K. J., & de Jonge, P. (2013). Diagnostic heterogeneity in psychiatry: Towards an empirical solution. BMC Medicine, 11(1), 201. https://doi.org/10.1186/1741-7015-11-201
Whitaker, R. (2010). Anatomy of an epidemic: Magic bullets, psychiatric drugs and the astonishing rise of mental illness. New York, NY: Broadway Paperbacks.
Widiger, T. A., & Spitzer, R. L. (1991). Sex bias in the diagnosis of personality disorders: Conceptual and methodological issues. Clinical Psychology Review, 11(1), 1–22.
Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: Long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70(9), 913–920. https://doi.org/10.1001/jamapsychiatry.2013.19
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 The Author(s)
About this chapter
Cite this chapter
Hunter, N. (2018). A Plea for Change. In: Trauma and Madness in Mental Health Services. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-91752-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-91752-8_8
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-319-91751-1
Online ISBN: 978-3-319-91752-8
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)